Clinical Trials Browser

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03044743 2017-05-02

PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

Phase 1/2 Unknown

20 enrolled

GastrointestinalHead & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Stomach Neoplasms, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01412307 2015-08-11

LEBEN

Phase 1/2 Unknown

36 enrolled

Lymphoid

Hodgkin Disease

NCT02145923 2015-06-10

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Phase 1/2 Unknown

16 enrolled

Classical hematologyLymphoid

Anemia, Aplastic, Hodgkin Disease, Enterocolitis, Neutropenic

NCT02274584 2014-10-24

CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)

Phase 1/2 Unknown

20 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Large-Cell, Anaplastic

NCT02007811 2014-03-26

B-cell therapy

Phase 1/2 Unknown

15 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01983761 2013-11-18

Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Phase 1/2 Unknown

25 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes

NCT00179816 2010-10-11

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

Phase 1/2 Unknown

12 enrolled

GastrointestinalGenitourinaryLymphoidSarcoma

Hodgkin Disease, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Sarcoma, Sarcoma, Ewing, Hepatoblastoma

NCT00441818 2008-05-09

Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma

Phase 1/2 Unknown

59 enrolled

Lymphoid

Hodgkin Disease

Clinical Trials

BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

NICE-40

Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients

CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.

Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

GLIDE

PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

LEBEN

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)

B-cell therapy

Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma